Export

Certolizumab pegol
Essential medicine status
General description

INN
Certolizumab pegol
Medicine type
Biological agent
EML status history
First added in 2019 (TRS 1021) for Axial spondyloarthritis
Changed in 2019 (TRS 1021) for Crohn disease site
Recommendations